Jhudit Perez-Escuredo Selected Research

demycarosyl-3D-digitoxosylmithramycin SK

8/2019	The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042.
1/2019	Transcriptional Reprogramming and Inhibition of Tumor-propagating Stem-like Cells by EC-8042 in ERG-positive Prostate Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jhudit Perez-Escuredo Research Topics

Disease

3	Neoplasms (Cancer) 08/2019 - 04/2011
1	Squamous Cell Carcinoma of Head and Neck 08/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 08/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Adenocarcinoma 04/2011

Drug/Important Bio-Agent (IBA)

2	demycarosyl-3D-digitoxosylmithramycin SKIBA 08/2019 - 01/2019
1	saracatinibIBA 08/2019
1	Dasatinib (BMS 354825)FDA Link 08/2019
1	Plicamycin FDA Link 08/2019
1	src-Family KinasesIBA 08/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	Proteins (Proteins, Gene)FDA Link 04/2011
1	Biomarkers (Surrogate Marker)IBA 04/2011

Therapy/Procedure

1	Precision Medicine 01/2019
1	Therapeutics 01/2019